𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Asparagine synthetase activity of the leukocytes in patients with acute leukemia

✍ Scribed by T. T. Berezov; L. V. Zherdeva

Publisher
Springer US
Year
1973
Tongue
English
Weight
241 KB
Volume
76
Category
Article
ISSN
0007-4888

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Mass spectrometric quantification of asp
Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients
✍ Susan E. Abbatiello; Yuan-Xiang Pan; Mi Zhou; Alan S. Wayne; Timothy D. Veenstra πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier 🌐 English βš– 542 KB

The appearance of asparaginase-resistant acute lymphoblastic leukemia (ALL) in transformed cell lines has been correlated with increased expression of asparagine synthetase (ASNS). Recent measurements using mRNA-based assays have raised doubts, however, as to the importance of ASNS protein in the ce

Activity of alemtuzumab in patients with
Activity of alemtuzumab in patients with CD52-positive acute leukemia
✍ Raoul Tibes; Michael J. Keating; Alessandra Ferrajoli; William Wierda; Farhad Ra πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

## Abstract ## BACKGROUND Alemtuzumab is a humanized monoclonal antibody directed against the cell surface antigen CD52 and has demonstrated activity in chronic lymphocytic leukemia and other CD52‐positive lymphoproliferative disorders. Because CD52 also is expressed on acute leukemic blasts, the

Telomerase activity is prognostic in ped
Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia : Comparison with adult acute myeloid leukemia
✍ Srdan Verstovsek; Taghi Manshouri; Franklin O. Smith; Francis J. Giles; Jorge Co πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 130 KB πŸ‘ 2 views

## Abstract ## BACKGROUND Significantly elevated telomerase activity (TA) has been found in samples from patients with almost all malignant hematologic diseases. The impact of elevated TA on the course of pediatric patients with acute myeloid leukemia (P‐AML) is unknown. ## METHODS Using a modif